menu
아주대학교 의학문헌정보센터
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
repository
BROWSE
Communities & Collections
AJOU Authors
Title
Publication Year
Keyword
Keyword (Historical Materials)
Journal
AJOU Open Repository
Journal Papers
School of Medicine / Graduate School of Medicine
Hematology-Oncology
396
search for
or browse
AJOU Authors
Title
Publication Year
Keyword
Keyword (Historical Materials)
Journal
Subscribe to this collection to receive daily e-mail notification of new additions
Pub Year
Title
AJOU Author(s)
2012
Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases
김보영
,
김세혁
,
김영배
,
김장희
,
신승수
,
이기범
,
이현우
,
정선용
,
한재호
2018
Patient's Cognitive Function and Attitudes towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis
이현우
2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
강석윤
2014
Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
강석윤
,
박준성
,
안미선
,
이현우
,
정성현
,
최용원
,
최진혁
2019
PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data
고영화
,
이수진
,
이현우
,
정준호
,
한재호
,
함석진
2022
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
정성현
,
최윤석
2019
Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)
강석윤
2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
권민석
2021
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
강석윤
2020
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07
안미선
2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
정성현
2022
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)
안미선
2016
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
정성현
2015
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
안미선
2012
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study
김효철
2017
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
박준성
2007
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
-
2013
Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.
강석윤
2012
Phospholipase C activator m-3M3FBS protects against morbidity and mortality associated with sepsis
박준성
2017
Phospholipase Cgamma1 suppresses foreign body giant cell formation by maintaining RUNX1 expression in macrophages
박준성
1
10
11
12
13
14
15
16
17
18
19
Browse
Communities & Collections
Ajou Authors
Titles
Publication Year
Keyword
Journal
Guide
아주대학교 의학문헌정보센터